These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9511137)
1. New drugs in development targeted to women's health. Meisler JG J Womens Health; 1998 Feb; 7(1):93-117. PubMed ID: 9511137 [No Abstract] [Full Text] [Related]
2. Tracking inclusion of women in clinical studies. Wood SF J Womens Health (Larchmt); 2009 Mar; 18(3):301-2. PubMed ID: 19231989 [No Abstract] [Full Text] [Related]
3. Review of the Drug Trials Snapshots Program of the US Food and Drug Administration: Women in Cardiovascular Drug Trials. Whyte J; Woodcock J; Wang J JAMA Intern Med; 2017 May; 177(5):724-727. PubMed ID: 28288256 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical research targets women. Hosp Health Netw; 1993 Aug; 67(15):22. PubMed ID: 8334467 [No Abstract] [Full Text] [Related]
5. Participation of women in clinical trials for new drugs approved by the food and drug administration in 2000-2002. Yang Y; Carlin AS; Faustino PJ; Motta MI; Hamad ML; He R; Watanuki Y; Pinnow EE; Khan MA J Womens Health (Larchmt); 2009 Mar; 18(3):303-10. PubMed ID: 19243271 [TBL] [Abstract][Full Text] [Related]
6. Manufacturing uncertainty: adverse effects of drug development for women. Peppin P Int J Law Psychiatry; 2003; 26(5):515-32. PubMed ID: 14522223 [No Abstract] [Full Text] [Related]
7. News from the Society for Women's Health Research: FDA doing poor job of monitoring drugs for sex differences. Greenberger P J Womens Health Gend Based Med; 2001 Nov; 10(9):829-30. PubMed ID: 11747675 [No Abstract] [Full Text] [Related]
8. Success rates for new drugs entering clinical testing in the United States. DiMasi JA Clin Pharmacol Ther; 1995 Jul; 58(1):1-14. PubMed ID: 7628176 [No Abstract] [Full Text] [Related]
9. Clinical development of therapeutic recombinant proteins. Reichert JM; Paquette C Biotechniques; 2003 Jul; 35(1):176-8, 180, 182-5. PubMed ID: 12866419 [TBL] [Abstract][Full Text] [Related]
10. Participation of women in clinical trials of drug therapies: a context for the controversies. Prout MN; Fish SS Medscape Womens Health; 2001 Oct; 6(5):1. PubMed ID: 11698923 [TBL] [Abstract][Full Text] [Related]
11. There is no women's health crisis. Satel SL Public Interest; 1998; 130():21-33. PubMed ID: 11658109 [No Abstract] [Full Text] [Related]
12. Recombinant protein therapeutics--success rates, market trends and values to 2010. Pavlou AK; Reichert JM Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654 [No Abstract] [Full Text] [Related]
13. US new drug applications increasingly rely on trials conducted abroad. Tanne JH BMJ; 2010 Jul; 341():c3616. PubMed ID: 20605887 [No Abstract] [Full Text] [Related]
14. Office of Women's Health, Food and Drug Administration: future directions for women's health. Wood SF J Am Med Womens Assoc (1972); 2001; 56(4):197-8. PubMed ID: 11759792 [TBL] [Abstract][Full Text] [Related]
15. Women's health and the FDA. Wood SF N Engl J Med; 2005 Oct; 353(16):1650-1. PubMed ID: 16236734 [No Abstract] [Full Text] [Related]
16. Drugs and Medical Devices: Adverse Events and the Impact on Women's Health. Carey JL; Nader N; Chai PR; Carreiro S; Griswold MK; Boyle KL Clin Ther; 2017 Jan; 39(1):10-22. PubMed ID: 28069260 [TBL] [Abstract][Full Text] [Related]
18. Women abound in NIH trials. Holden C Science; 2008 Oct; 322(5899):219. PubMed ID: 18845746 [No Abstract] [Full Text] [Related]
19. The NIH Women's Health Initiative: its evolution and expected contributions to women's health. Finnegan LP Am J Prev Med; 1996; 12(5):292-3. PubMed ID: 8909634 [No Abstract] [Full Text] [Related]
20. Drug development and women: an overview. Gibaldi M Pharmacotherapy; 1992; 12(5):365-8. PubMed ID: 1437698 [No Abstract] [Full Text] [Related] [Next] [New Search]